Empagliflozin improves clinical outcomes for HFpEF in EMPEROR-Preserved

被引：3
|
作者：
Huynh, Karina
机构：
[1] Nature Reviews Cardiology,
来源：
NATURE REVIEWS CARDIOLOGY | 2021年 / 18卷 / 11期
关键词：
D O I：
10.1038/s41569-021-00627-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：737 / 737
页数：1
相关论文
共 50 条
  • [21] Design and rationale of the EMPagliflozin outcomE tRial in patients with chrOnic heaRt failure (EMPEROR-Preserved)
    Butler, J.
    Packer, M.
    Filippatos, G.
    Zannad, F.
    Salsali, A.
    Kimura, K.
    Schnee, J.
    Zeller, C.
    Pocock, S.
    George, J.
    Brueckmann, M.
    Anker, S. D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 232 - 232
  • [22] Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection: The EMPEROR-Preserved Trial
    Butler, Javed
    [J]. CIRCULATION, 2021, 144 (25) : E585 - E586
  • [23] Impact of empagliflozin on insulin use in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes: sub-analysis from EMPEROR-Preserved trial
    Butler, J.
    Green, J. B.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S285 - S286
  • [24] Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
    Butler, Javed
    Filippatos, Gerasimos
    Siddiqi, Tariq Jamal
    Brueckmann, Martina
    Bohm, Michael
    Chopra, Vijay K.
    Ferreira, Joao Pedro
    Januzzi, James L.
    Kaul, Sanjay
    Pina, Ileana L.
    Ponikowski, Piotr
    Shah, Sanjiv J.
    Senni, Michele
    Vedin, Ola
    Verma, Subodh
    Peil, Barbara
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    Anker, Stefan D.
    [J]. CIRCULATION, 2022, 145 (03) : 184 - 193
  • [25] EFFECTS OF EMPAGLIFLOZIN IN FEMALE AND MALE PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION: RESULTS FROM THE EMPEROR-PRESERVED TRIAL
    Butler, Javed
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 311 - 311
  • [26] Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction EMPEROR-Preserved Trial
    Packer, Milton
    Butler, Javed
    Zannad, Faiez
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Carson, Peter
    Anand, Inder
    Doehner, Wolfram
    Haass, Markus
    Komajda, Michel
    Miller, Alan
    Pehrson, Steen
    Teerlink, John R.
    Schnaidt, Sven
    Zeller, Cordula
    Schnee, Janet M.
    Anker, Stefan D.
    [J]. CIRCULATION, 2021, 144 (16) : 1284 - 1294
  • [27] Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved
    Rastogi, Tripti
    Ferreira, Joao Pedro
    Butler, Javed
    Kraus, Bettina Johanna
    Mattheus, Michaela
    Brueckmann, Martina
    Filippatos, Gerasimos
    Wanner, Christoph
    Pocock, Stuart J.
    Packer, Milton
    Anker, Stefan D.
    Zannad, Faiez
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 885 - 896
  • [28] Journey from EMPA-REG to CARMELINA to EMPEROR-Preserved: Empagliflozin/Linagliptin in Heart Failure and Diabetes
    Gadve, Sharvil S.
    Chavanda, Sneha
    Gogate, Yashpal V.
    Harale, Vinayak
    Dasgupta, Arundhati
    Patwardhan, Milind
    [J]. JOURNAL OF DIABETOLOGY, 2022, 13 (03) : 189 - 198
  • [29] Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
    Arutyunov, Gregory P.
    Lopatin, Yuri M.
    Ametov, Aleksandr S.
    Ageev, Fail T.
    Antsiferov, Mikhail B.
    Villevalde, Svetlana V.
    Vinogradova, Nadezhda G.
    Galstyan, Gagik R.
    Galyavich, Albert S.
    Gilyarevskiy, Sergey R.
    Glezer, Maria G.
    Zhirov, Igor, V
    Ilyin, Mikhail, V
    Lebedeva, Anastasiya Iu
    Nedogoda, Sergey M.
    Salukhov, Vladimir V.
    Tarlovskaya, Ekaterina, I
    Tereshchenko, Sergey N.
    Fomin, Igor, V
    Khalimov, Iurii Sh
    Khasanov, Niaz R.
    Cherkashin, Dmitriy, V
    Yakushin, Sergey S.
    [J]. TERAPEVTICHESKII ARKHIV, 2021, 93 (12): : 1491 - 1497
  • [30] Drug treatment with empagliflozin was beneficial in people with heart failure with preserved ejection fraction: plain language summary of the EMPEROR-Preserved study
    Zannad, Faiez
    Macari, Steven
    [J]. FUTURE CARDIOLOGY, 2023, 19 (14) : 671 - 677
12345